Sab Biotherapeutics Inc. (SABS)

Market is closed
Sector: Healthcare

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Caligan Partners

David Johnson

7,967,207 $31,072,107 1.46%
2.
Vivo Capital

Albert Cha And Frank Kung

7,299,909 $28,469,645 -37% 2.6%
3.
Perceptive Advisors

Joseph Edelman

6,627,501 $25,847,254 +4% 0.39%
4.
Adage Capital Management

Phill Gross And Robert Atchinson

6,405,553 $24,981,657 +89% 0.04%
5.
RA Capital Management

Peter Kolchinsky

4,401,500 $17,165,850 0.15%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$0.88 1,740 $1,531.20 5,232,304 2023-12-07 Filing
$0.90 5,000 $4,500.00 5,000 2023-11-30 Filing
$0.89 11,000 $9,841.70 219,001 2023-11-29 Filing
$0.73 10,000 $7,297.00 4,993,090 2022-09-13 Filing
$0.74 14,000 $10,315.20 5,230,564 2022-09-07 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$7.90 278 $2,196.20 0 2021-10-26 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 3,066,016 $11,957,462 0%
2. 2,972,929 $11,594,423 0%
3. 1,525,000 $5,947,500 0.27%
4. 1,481,660 $5,778,474 0.08%
5. 1,277,185 $4,981,704 0%
News See All